INTECH Investment Management’s RxSight RXST Stock Holding History

INTECH Investment Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.9K	Sell	10,533 -4,255	-29%	-$35.3K	﹤0.01%	1973
2025 Q4	$154K	Sell	14,788 -11,153	-43%	-$112K	﹤0.01%	2060
2025 Q3	$233K	Sell	25,941 -6,661	-20%	-$58.5K	﹤0.01%	1974
2025 Q2	$424K	Hold	32,602	–	–	﹤0.01%	1703
2025 Q1	$823K	Buy	32,602 +12,257	+60%	+$364K	0.01%	1321
2024 Q4	$699K	Buy	20,345 +8,254	+68%	+$372K	0.01%	1359
2024 Q3	$598K	Buy	+12,091	New	+$619K	0.01%	1136

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

INTECH Investment Management's RXST Position: Q1 2026 in Review

INTECH Investment Management reduced its RxSight (RXST) stake by 29% in Q1 2026, selling an estimated $35.3K and leaving 10,533 shares worth $64.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

INTECH Investment Management first reported a position in RXST in Q3 2024 and has held it in 7 quarters since. The position peaked at $823K in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

INTECH Investment Management held 10,533 shares of RxSight worth $64.9K as of Q1 2026.
INTECH Investment Management sold 4,255 RxSight shares in Q1 2026, an estimated $35.3K.
RxSight made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1973 holding.
INTECH Investment Management first reported a position in RxSight in Q3 2024 and has held it in 7 quarters since.
INTECH Investment Management's RxSight position peaked at $823K in Q1 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.